As of 2026-01-05, the Relative Valuation of Catalyst Pharmaceuticals Inc (CPRX) is 36.59 USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.15 USD, the upside of Catalyst Pharmaceuticals Inc based on Relative Valuation is 58.1%.
The range of the Relative Valuation is 26.40 - 52.51 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 20.3x | 19.0x |
| Forward P/E multiples | 18.1x - 36.0x | 27.0x |
| Fair Price | 26.40 - 52.51 | 36.59 |
| Upside | 14.0% - 126.8% | 58.1% |
| Date | P/E |
| 2026-01-02 | 13.07 |
| 2025-12-31 | 13.18 |
| 2025-12-30 | 13.15 |
| 2025-12-29 | 13.59 |
| 2025-12-26 | 13.75 |
| 2025-12-24 | 13.81 |
| 2025-12-23 | 13.68 |
| 2025-12-22 | 13.73 |
| 2025-12-19 | 13.41 |
| 2025-12-18 | 13.37 |
| 2025-12-17 | 13.55 |
| 2025-12-16 | 13.66 |
| 2025-12-15 | 13.66 |
| 2025-12-12 | 13.34 |
| 2025-12-11 | 12.96 |
| 2025-12-10 | 12.88 |
| 2025-12-09 | 12.74 |
| 2025-12-08 | 13.08 |
| 2025-12-05 | 13.29 |
| 2025-12-04 | 13.03 |
| 2025-12-03 | 13.05 |
| 2025-12-02 | 12.78 |
| 2025-12-01 | 12.81 |
| 2025-11-28 | 13.22 |
| 2025-11-26 | 13.23 |
| 2025-11-25 | 13.32 |
| 2025-11-24 | 13.28 |
| 2025-11-21 | 13.15 |
| 2025-11-20 | 12.86 |
| 2025-11-19 | 12.71 |
| 2025-11-18 | 12.80 |
| 2025-11-17 | 12.74 |
| 2025-11-14 | 13.09 |
| 2025-11-13 | 13.00 |
| 2025-11-12 | 12.87 |
| 2025-11-11 | 13.05 |
| 2025-11-10 | 12.18 |
| 2025-11-07 | 12.08 |
| 2025-11-06 | 11.85 |
| 2025-11-05 | 12.07 |
| 2025-11-04 | 12.05 |
| 2025-11-03 | 12.11 |
| 2025-10-31 | 12.01 |
| 2025-10-30 | 11.84 |
| 2025-10-29 | 11.87 |
| 2025-10-28 | 12.06 |
| 2025-10-27 | 12.08 |
| 2025-10-24 | 11.84 |
| 2025-10-23 | 11.71 |
| 2025-10-22 | 11.84 |